Takeda Pharmaceutical Company Limited
Stock Forecast, Prediction & Price Target
Takeda Pharmaceutical Company Limited Financial Estimates
Takeda Pharmaceutical Company Limited Revenue Estimates
Takeda Pharmaceutical Company Limited EBITDA Estimates
Takeda Pharmaceutical Company Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | 3/31/2028 | 3/31/2029 |
Revenue
% change YoY
| $3.19T N/A | $3.56T 11.60% | $4.26T 19.46% | Avg: $4.03T Low: $3.99T High: $4.07T avg. -5.33% | Avg: $4.13T Low: $4.08T High: $4.18T avg. 2.43% | Avg: $4.25T Low: $4.20T High: $4.30T avg. 2.93% | Avg: $4.38T Low: $4.33T High: $4.44T avg. 3.10% |
Net Income
% change YoY
| $376.00B N/A | $230.05B -38.81% | $144.06B -37.37% | Avg: $93.30B Low: $85.37B High: $101.23B avg. -35.23% | Avg: $133.48B Low: $131.34B High: $135.61B avg. 43.05% | Avg: $190.98B Low: $187.92B High: $194.04B avg. 43.08% | Avg: $214.61B Low: $211.17B High: $218.04B avg. 12.37% |
EBITDA
% change YoY
| $1.17T N/A | $1.05T -10.40% | $874.60B -16.88% | Avg: $1.18T Low: $1.17T High: $1.19T avg. 35.27% | Avg: $1.21T Low: $1.19T High: $1.22T avg. 2.43% | Avg: $1.24T Low: $1.23T High: $1.26T avg. 2.93% | Avg: $1.28T Low: $1.27T High: $1.30T avg. 3.10% |
EPS
% change YoY
| $240.72 N/A | $147.14 -38.87% | $92.09 -37.41% | Avg: $59.04 Low: $54.02 High: $64.06 avg. -35.88% | Avg: $84.46 Low: $83.11 High: $85.82 avg. 43.05% | Avg: $120.85 Low: $118.92 High: $122.79 avg. 43.08% | Avg: $135.8 Low: $133.63 High: $137.98 avg. 12.37% |
Operating Expenses
% change YoY
| $1.69T N/A | $2.00T 18.12% | $2.61T 30.82% | Avg: $1.05T Low: $1.04T High: $1.06T avg. -59.60% | Avg: $1.08T Low: $1.07T High: $1.09T avg. 2.43% | Avg: $1.11T Low: $1.10T High: $1.12T avg. 2.93% | Avg: $1.14T Low: $1.13T High: $1.16T avg. 3.10% |
FAQ
What is Takeda Pharmaceutical Company Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 15.81% in 2026-2029.
We have gathered data from 2 analysts. Their low estimate is 85.37B, average is 93.30B and high is 101.23B.
What is Takeda Pharmaceutical Company Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.78% in 2026-2029.
We have gathered data from 2 analysts. Their low revenue estimate is $3.99T, average is $4.03T and high is $4.07T.
What is Takeda Pharmaceutical Company Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.65% in 2026-2029.
We have gathered data from 2 analysts. Their low earnings per share estimate is $54.02, average is $59.04 and high is $64.05.